Merrimack
About Merrimack
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack’s development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.
For more, please visit Merrimack’s website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
Company Details
10M-25M
Biotechnology Research
51-200 employees
Public Company
Cambridge, Massachusetts
United States
Frequently Asked Questions about
What is Merrimack's industry?
Merrimack operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does Merrimack have?
Merrimack has approximately 51-200 employees employees.
Where is Merrimack's based?
Merrimack is based in Cambridge, Massachusetts, United States.
Is Merrimack publicly listed?
Yes. Merrimack is a publicly traded company.
How can I contact Merrimack's investor relations team?
You can reach Merrimack’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.